Form 4 for STOK Stoke Therapeutics, Inc.
Accepted 2026-06-18 16:18:58 ET · period of report 2026-06-16 · accession 0001966716-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-18 16:18 | 2026-06-16 | STOK | Allan Jonathan | GC, CORP SEC | S - Sale | $29.95 | -1,457 | 18.1K | -7% | -$43.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-16 | S | D | 1,457 | $29.95 | 18,086 | D | — | — | (F1) This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025. |